BMI isn’t destiny: how doctors actually weigh eligibility

BMI is where a prescribing conversation starts, not a pass/fail test — and it has real limitations worth knowing about.

V

By The Vive Team

August 2026 · 6 min read

Almost every guide to weight-loss medication opens with a BMI threshold, which leaves a lot of people doing arithmetic and concluding they are either automatically in or automatically out. Neither conclusion is safe to draw on your own.

What BMI is actually for

Body mass index is weight divided by height squared. It is cheap, fast, and reproducible, which is precisely why it became the standard population-level screening tool — you can calculate it for a whole country from data you already have.

In a prescribing conversation it does useful work: it gives a physician a starting sense of where you sit, and it is the metric most clinical trials in this field enrolled on, so it is the metric the evidence is expressed in.

That is its job. It was never designed to be a verdict about an individual.

Where it falls down

BMI is a ratio of two numbers, and it cannot see anything else:

  • It does not distinguish muscle from fat. A muscular person can land in the "overweight" band while being metabolically healthy.
  • It says nothing about where weight sits. Visceral fat around the organs carries different risk from the same weight distributed elsewhere.
  • Its standard bands were derived largely from European populations, and there is ongoing discussion about whether the same cut-offs are appropriate across different ethnic groups — including Asian populations, where metabolic risk can appear at lower BMI values.
  • It is a snapshot. It cannot see whether you have been stable for a decade or gained rapidly in a year, which are clinically different situations.

You can calculate yours with our BMI calculator, and see fat distribution separately with the waist-to-hip tool — but read both as inputs, not answers.

What a physician weighs alongside it

BMI is one line in a fuller picture. A prescribing decision also takes account of:

  • Weight-related conditions you already have — blood pressure, blood sugar, lipids, sleep apnea, joint load.
  • Your weight history, including what you have already tried and how it went.
  • Current medicines and how they would interact.
  • Contraindications, which override everything else regardless of BMI. See what disqualifies you.
  • What you are actually trying to achieve, and whether medication is the right tool for it.

Why this cuts both ways

People assume this framing only helps borderline cases qualify. It does not. Someone whose BMI sits well inside the treated range can still be declined — because of a contraindication, an interaction, or a physician’s judgment that medication is not the right approach for them right now.

A number cannot make that call. That is the entire reason the review exists.

GLP-1 medication is prescription-only, and results vary from person to person. Take the assessment and let a licensed physician read the whole picture. Read the Important Safety Information first.

// References

  1. 1.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989–1002. View study →
  2. 2.Obesity-management consensus literature on BMI as a screening tool, its limitations at individual level, and population-specific cut-off considerations.

Provided for education only. Trial averages describe study populations, not any individual’s expected result. This is not medical advice — GLP-1 medication is prescription-only and outcomes vary.

Medically reviewed by Vive’s licensed physicians. Meet the clinicians →

Curious what’s right for you?

Take the 3-min quiz →